Catalyst Wire Dossier Catalyst Wire Dossier

VYALEV

foscarbidopa/foslevodopa · AbbVie Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VYALEV, covering 2024-10-16 to 2026-03-19. Get the full timeline:

Most recent: FDA Approved: VYALEV — Supplemental Application (AbbVie Inc.)

See pricing